Log in to save to my catalogue

Toxic Epidermal Necrolysis Observed in a Patient With the HLA-B1502 Treated With Levofloxacin

Toxic Epidermal Necrolysis Observed in a Patient With the HLA-B1502 Treated With Levofloxacin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3112525925

Toxic Epidermal Necrolysis Observed in a Patient With the HLA-B1502 Treated With Levofloxacin

About this item

Full title

Toxic Epidermal Necrolysis Observed in a Patient With the HLA-B1502 Treated With Levofloxacin

Publisher

United States: Elsevier Inc

Journal title

Clinical therapeutics, 2024-12, Vol.46 (12), p.1082-1085

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Highlights•There are a few reports on levofloxacin-induced TEN and the relationship between levofloxacin-induced TEN and genetic variants has not been investigated. •This is the first report of levofloxacin-induced TEN suspected to be caused by mutations in the HLA-B*1502 allele.

Alternative Titles

Full title

Toxic Epidermal Necrolysis Observed in a Patient With the HLA-B1502 Treated With Levofloxacin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3112525925

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3112525925

Other Identifiers

ISSN

0149-2918,1879-114X

E-ISSN

1879-114X

DOI

10.1016/j.clinthera.2024.09.014

How to access this item